Hamed Movahed

Hamed Movahed

Auto-generated profile, based on publicly available information

Hamed Movahed

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Hematology
Verified
Journal Article
Open access
ETErfan Taherifard
Erfan Taherifard
ETEhsan Taherifard
Ehsan Taherifard
HMHamed Movahed
Hamed Movahed
MMMohammad Reza Mousavi
Mohammad Reza Mousavi
As COVID-19 is a new emerging disease, the hematological/immunological changes that develop in the infected patients remain unknown. This study aims to systematically review the hematologic autoimm...

6 May 2022 in Infectious Diseases
Verified
Journal Article
Closed access
ETEhsan Taherifard
Ehsan Taherifard
HMHamed Movahed
Hamed Movahed
SSSima Kiani Salmi
Sima Kiani Salmi
ATAli Taherifard
Ali Taherifard
SASaeed Abdollahifard
Saeed Abdollahifard
ETErfan Taherifard
Erfan Taherifard
Dysfunction of both the innate and the adaptive immune systems is observed in severe coronavirus disease 2019 which, together with administration of immunosuppressive drugs, could lead to cytomegal...

13 February 2024 in Pediatric Blood & Cancer
Verified
Journal Article
Closed access
ETErfan Taherifard
Erfan Taherifard
HMHamed Movahed
Hamed Movahed
ETEhsan Taherifard
Ehsan Taherifard
ASAlireza Sadeghi
Alireza Sadeghi
NENiloofar Dehdari Ebrahimi
Niloofar Dehdari Ebrahimi
HMHossein Movahed
Hossein Movahed

30 August 2025 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
MGMaryam Ghadimi
Maryam Ghadimi
GGGordon Guyatt
Gordon Guyatt
CZCarlos Zaror
Carlos Zaror
JLJoão Pedro Lima
João Pedro Lima
SGSana Gupta
Sana Gupta
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
To explore the extent to which trustworthiness of treatment guidelines has changed since the introduction of Institute of Medicine (IOM) standards. In this systematic survey, we searched Medline, Embase, PsycINFO, and Trip from January to December 2010 (pre-IOM) and 2022 (post-IOM) for guidelines that were informed by a systematic review of evidence, written in English, and included recommendations for the treatment of any health conditions in individuals of any age. Using the 10-item modified National Guideline Clearinghouse Extent of Adherence to Trustworthy Standards (NEATS) instrument, paired reviewers independently assessed trustworthiness of 70 randomly selected guidelines from 2010 and 70 from 2022. We calculated mean difference (MD) and corresponding 95% confidence interval (CI) comparing guidelines from 2010 with 2022 for mean score across four critical items, mean score across all items, and score of individual items on 5-point Likert scales in which 1 was least adherence and 5, highest adherence. We also explored change in the proportion of guidelines that achieved a mean score of 4 or higher across critical items. The average of mean scores increased from 2.28 to 2.74 (MD: 0.46, 95% CI: 0.13-0.79) across critical items and from 2.20 to 2.52 (MD: 0.32, 95% CI: 0.08-0.56) across all items. The proportion of guidelines with a mean score of 4 or higher across critical items increased from 2.9% to 18.6% (absolute difference: 15.7%, 95% CI: 5.8%-25.6%). The items with the greatest increase in the average score included disclosure of funding sources and disclosure and management of financial conflict of interests, followed by a smaller increase in synthesis of evidence, study selection, and search strategy. Other items showed little to no change from 2010. As assessed by the modified NEATS instrument, although trustworthiness of treatment guidelines has improved after the introduction of IOM standards, improvements proved modest and post-IOM guidelines trustworthiness remains suboptimal.

23 June 2024 in Health Science Reports
Verified
Journal Article
Open access
ASAlireza Sadeghi
Alireza Sadeghi
ETEhsan Taherifard
Ehsan Taherifard
HMHamed Movahed
Hamed Movahed
AAAlireza Ahmadkhani
Alireza Ahmadkhani
NENiloofar Dehdari Ebrahimi
Niloofar Dehdari Ebrahimi
ETErfan Taherifard
Erfan Taherifard
Background: Despite advancements in the management of patients with sickle cell disease (SCD), the involvement of the cardiovascular system in these patients remains a significant concern. Cardiovascular manifestations of SCD are well‐documented, with electrocardiography (ECG) serving as a valuable diagnostic tool. Studies have reported a high rate of critical ECG findings in patients with SCD that warrants consideration when managing these patients, indicating the need for proactive cardiac screening and management strategies in this patient population. This study aims to systematically review the literature to identify sociodemographic, clinical, and paraclinical factors associated with ECG abnormalities in patients with SCD.Methods: A comprehensive search strategy will be employed across multiple online databases, including PubMed, Embase, Scopus, Web of Science, and Google Scholar, for published and gray literature. Eligible studies will include original articles reporting associations between sociodemographic, clinical, and paraclinical variables and a spectrum of ECG findings in patients with SCD. Independent reviewers will conduct the screening, quality assessment, and data extraction. Quantitative analyses will be performed under a random‐effect model using Comprehensive Meta‐Analysis software, with subgroup analyses based on SCD status, sickle hemoglobinopathy form, and age group.

11 August 2026 in Journal of Clinical Epidemiology
Verified
Journal Article
Open access
HMHamed Movahed
Hamed Movahed
RMReza Donald Mirza
Reza Donald Mirza
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
AIAlfonso Iorio
Alfonso Iorio
NDNiveditha Devasenapathy
Niveditha Devasenapathy
GGGordon Guyatt
Gordon Guyatt